1. Emergency physician survey: recombinant tissue plasminogen activator for stroke;Walsh;Annals Emerg Med,2006
2. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurologic Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study;Kwiatkowski;Ann Emerg Med,2005
3. Mann J. A Response to the NINDS Study Group’s “Imbalances in Baseline Stroke Severity and Outcome”. Available at http://jeffmann.net/soapbox/NINDS-ResponsetoAnnalsPaper.htm. Accessed August 9, 2006.